Choriogonadotropin Alpha: Brands, Price & Uses in Bangladesh

Choriogonadotropin Alpha is a recombinant form of human chorionic gonadotropin (hCG) used in the management of infertility as part of assisted reproductive technology (ART) and ovulation induction protocols. Its established indications include:

• Final oocyte/follicular maturation and triggering of ovulation in infertile women undergoing superovulation as part of an ART program (e.g., in-vitro fertilization), administered after adequate follicular development has been achieved with follicle-stimulating hormone (FSH) therapy.
• Induction of ovulation and pregnancy in anovulatory infertile women in whom the cause of infertility is functional and not due to primary ovarian failure, used as part of a combined ovulation-induction regimen together with gonadotropin therapy (adjunct/combination use, not as monotherapy).

Choriogonadotropin Alpha is intended for use only under the supervision of a physician experienced in the treatment of infertility, with appropriate ultrasound and hormonal monitoring. It is not indicated for use in males or for weight loss, and such uses are not supported by evidence.

Dosing of Choriogonadotropin Alpha must always be individualized by a fertility specialist based on ovarian response monitored by ultrasound and serum estradiol levels. General dosing patterns are summarized below; refer to the specific product labeling for the exact strength dispensed.

Choriogonadotropin Alpha is administered by subcutaneous injection, preferably in the abdomen, and may be self-administered by the patient after appropriate training, using the pre-filled syringe. It should be withheld if there is evidence of excessive ovarian response (e.g., markedly elevated estradiol or a large number of developing follicles), and the treating physician should be consulted, as proceeding under these circumstances increases the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy. Missed or mistimed doses should not be self-corrected; contact the treating physician immediately, as the timing of Choriogonadotropin Alpha relative to oocyte retrieval or intercourse is critical to treatment success.

The most commonly reported side effects of Choriogonadotropin Alpha include:

• Injection site reactions (pain, redness, bruising, or swelling) - the most frequently reported adverse effect.
• Abdominal pain or discomfort, bloating.
• Nausea, vomiting, headache.
• Post-procedural pelvic pain (in ART cycles).

Less common but serious effects include ovarian hyperstimulation syndrome (OHSS), multiple pregnancy, ectopic pregnancy, and (rarely) thromboembolic events or hypersensitivity/anaphylactic reactions - see Precautions and Warnings for details.